https://dynxp.com/
"Dynamix develops novel drugs that intervene with the metabolism of cancer cells and selectively block kinase signaling pathways in cancer and autoimmune diseases."
https://dynxp.com/company/
Dynamix is a venture-backed pharmaceutical company focused on the discovery and development of novel, targeted, small molecule drugs for treating patients suffering from cancer and
https://tracxn.com/d/companies/dynamixpharmaceuticals/__himHfzro3k8MlDs3Hre6p6bFFlKWkszdrXrsv562YHk
Mar 5, 2026 · Explore Dynamix Pharmaceuticals' in-depth company profile, including funding details, key investors, and leadership.
https://www.thepharmaletter.com/ones-to-watch/dynamix
6 days ago · Dynamix is an Israeli-based pharmaceutical company focused on the discovery and development of novel small molecule drugs for treating patients with cancer and autoim
https://pitchbook.com/profiles/company/40437-37
Information on valuation, funding, cap tables, investors, and executives for Dynamix Pharmaceuticals. Use the PitchBook Platform to explore the full profile.
https://www.bloomberg.com/quote/DNMX:US
2 days ago · Stock analysis for Dynamix Corp III (DNMX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
https://www.marketwatch.com/investing/stock/DNMX
3 days ago · View real-time stock prices and stock quotes for a full financial overview.
https://www.google.com/finance/beta/quote/DNMX:NASDAQ
DNMX:NASDAQ check_indeterminate_small Add to list Dynamix Corp III $9.98 arrow_downward -0.10%
https://www.cbinsights.com/company/dynamix-pharmaceuticals
Dynamix Pharmaceuticals is a biopharmaceutical company involved in the discovery and development of drugs for cancer and autoimmune diseases. The company works on drugs that target
https://www.marketbeat.com/stocks/NASDAQ/DNMX/
2 days ago · Should You Buy or Sell Dynamix Corp III Stock? Get The Latest DNMX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.